167 results on '"Tanaka, Kenichi A."'
Search Results
2. Elevated resting heart rate is associated with mortality in patients with chronic kidney disease.
- Author
-
Saito, Hirotaka, Tanaka, Kenichi, Ejiri, Hiroki, Kimura, Hiroshi, Shimabukuro, Michio, Asahi, Koichi, Watanabe, Tsuyoshi, and Kazama, Junichiro James
- Subjects
- *
HEART disease related mortality , *HEART beat , *CHRONIC kidney failure , *CHRONICALLY ill ,MORTALITY risk factors - Abstract
A higher heart rate is recognized as an independent risk factor for all-cause mortality and cardiovascular events in the general population. However, the association between elevated heart rate and clinical adverse outcomes in patients with non-dialysis-dependent chronic kidney disease (CKD) has not been sufficiently investigated. A total of 1353 participants enrolled in the Fukushima CKD Cohort Study were examined to investigate associations between resting heart rate and clinical adverse outcomes using Cox proportional hazards analysis. The primary outcome of the present study was all-cause mortality, with cardiovascular events as the secondary outcome. Participants were stratified into four groups based on resting heart rate levels at baseline (heart rate < 70/min, ≥ 70 and < 80/min, ≥ 80 and < 90/min, and ≥ 90/min). During the median observation period of 4.9 years, 123 participants died, and 163 cardiovascular events occurred. Compared with the reference level heart rate < 70/min group, the adjusted hazard ratios (HRs) for all-cause mortality were 1.74 (1.05–2.89) and 2.61 (1.59–4.29) for the heart rate ≥ 80 and < 90/min group and heart rate ≥ 90/min group, respectively. A significantly higher risk of cardiovascular events was observed in the heart rate ≥ 80/min and < 90/min group (adjusted HR 1.70, 1.10–2.62), but not in the heart rate ≥ 90/min group (adjusted HR 1.45, 0.90–2.34). In patients with non-dialysis-dependent CKD, a higher resting heart rate was associated with increased all-cause mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Predicting CKD progression using time-series clustering and light gradient boosting machines.
- Author
-
Saito, Hirotaka, Yoshimura, Hiroki, Tanaka, Kenichi, Kimura, Hiroshi, Watanabe, Kimio, Tsubokura, Masaharu, Ejiri, Hiroki, Zhao, Tianchen, Ozaki, Akihiko, Kazama, Sakumi, Shimabukuro, Michio, Asahi, Koichi, Watanabe, Tsuyoshi, and Kazama, Junichiro J.
- Subjects
CHRONIC kidney failure ,BOOSTING algorithms ,KIDNEY physiology ,TIME series analysis ,GLOMERULAR filtration rate ,BODY mass index - Abstract
Predicting the transition of kidney function in chronic kidney disease is difficult as specific symptoms are lacking and often overlooked, and progress occurs due to complicating factors. In this study, we applied time-series cluster analysis and a light gradient boosting machine to predict the trajectories of kidney function in non-dialysis dependent chronic kidney disease patients with baseline estimated glomerular filtration rate (GFR) ≥ 45 mL/min/1.73 m
2 . Based on 5-year changes in estimated GFR, participants were stratified into groups with similar trajectories by cluster analysis. Next, we applied the light gradient boosting machine algorithm and Shapley addictive explanation to develop a prediction model for clusters and identify important parameters for prediction. Data from 780 participants were available for analysis. Participants were classified into five classes (Class 1: n = 78, mean [± standard deviation] estimated GFR 100 ± 19.3 mL/min/1.73 m2 ; Class 2: n = 176, 76.0 ± 9.3 mL/min/1.73 m2 ; Class 3: n = 191, 59.8 ± 5.9 mL/min/1.73 m2 ; Class 4: n = 261, 52.7 ± 4.6 mL/min/1.73 m2 ; and Class 5: n = 74, 53.5 ± 12.0 mL/min/1.73 m2 ). Declines in estimated GFR were 8.9% in Class 1, 12.2% in Class 2, 4.9% in Class 3, 12.0% in Class 4, and 45.1% in Class 5 during the 5-year period. The accuracy of prediction was 0.675, and the top three most important Shapley addictive explanation values were 1.61 for baseline estimated GFR, 0.12 for hemoglobin, and 0.11 for body mass index. The estimated GFR transition of patients with preserved chronic kidney disease mostly depended on baseline estimated GFR, and the borderline for estimated GFR trajectory was nearly 50 mL/min/1.73 m2 . [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
4. Lateral olfactory tract usher substance (LOTUS), an endogenous Nogo receptor antagonist, ameliorates disease progression in amyotrophic lateral sclerosis model mice.
- Author
-
Ikeda, Takuya, Takahashi, Keita, Higashi, Minatsu, Komiya, Hiroyasu, Asano, Tetsuya, Ogasawara, Akihiro, Kubota, Shun, Hashiguchi, Shunta, Kunii, Misako, Tanaka, Kenichi, Tada, Mikiko, Doi, Hiroshi, Takeuchi, Hideyuki, Takei, Kohtaro, and Tanaka, Fumiaki
- Published
- 2023
- Full Text
- View/download PDF
5. Impact of red blood cell distribution width–albumin ratio on prognosis of patients with CKD.
- Author
-
Kimura, Hiroshi, Tanaka, Kenichi, Saito, Hirotaka, Iwasaki, Tsuyoshi, Kazama, Sakumi, Shimabukuro, Michio, Asahi, Koichi, Watanabe, Tsuyoshi, and Kazama, Junichiro James
- Subjects
- *
ERYTHROCYTES , *CHRONIC kidney failure , *RECEIVER operating characteristic curves , *PROGNOSIS , *MULTIVARIABLE testing , *MEDIAN (Mathematics) , *KAPLAN-Meier estimator - Abstract
The red blood cell distribution width–albumin ratio (RAR) is a prognostic factor for adverse outcomes in various populations. However, whether RAR is associated with renal outcomes remains unclear. Therefore, we aimed to investigate the impact of RAR on the prognosis in patients with chronic kidney disease (CKD). We conducted a retrospective cohort study using 997 CKD patients who were enrolled in the Fukushima Cohort Study. Patients were categorized into tertiles (T1-3) according to the baseline RAR. The associations of RAR with end-stage kidney disease (ESKD) were assessed using Kaplan–Meier curves and multivariable cox regression analyses. Receiver operating characteristic (ROC) curves were performed to test whether significant differences were present between red cell distribution width (RDW) and RAR. The median age was 66, 57% were men, the median eGFR was 47.8 ml/min/1.73 m2, and the median value of RAR was 3.5. The higher RAR group showed an increased risk for ESKD in the Kaplan–Meier curve analysis. Compared to the lowest RAR group, higher RAR groups had a higher risk of ESKD (hazard ratio [HR] 1.37, 95% CI 0.68–2.78 and 2.92, 95% CI 1.44–5.94) for T2 and T3 groups, respectively. ROC curve analysis proved that the discriminating ability of RAR for ESKD was superior to RDW. A higher RAR value was associated with worse renal outcomes in patients with CKD. RAR could be a convenient and useful prognostic marker for renal prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare.
- Author
-
Pathak, Rashmi, Leslie, Macall, Dondapati, Priya, Davis, Rachel, Tanaka, Kenichi, Jett, Elizabeth, Chervoneva, Inna, and Tanaka, Takemi
- Abstract
Background: Substantial evidence indicates that delay of first treatment after diagnosis is associated with poorer survival outcomes in breast cancer. Accordingly, the Commission on Cancer introduced a quality measure for receipt of therapeutic surgery within 60 days of diagnostic biopsy for stage I–III breast cancer patients in the non-neoadjuvant setting. It is unknown, however, what may contribute to mortality associated with treatment delay. Therefore, we investigated whether biopsy type moderates the effect of the mortality risk posed by treatment delay. Methods: Retrospective analysis of 31,306 women with stage I–III breast cancer diagnosed between 2003 and 2013 selected from the SEER-Medicare database was performed to determine whether needle biopsy type [core needle biopsy (CNB) or vacuum-assisted biopsy (VAB)] impacts time to treatment (TTT)-associated survival outcomes. Multivariable Fine-Gray competing risk survival models, adjusted for inverse propensity score weights, were used to determine the association between biopsy type, TTT, and breast cancer-specific mortality (BCSM). Results: TTT ≥ 60 days was associated with 45% higher risk of BCSM (sHR = 1.45, 95% CI 1.24–1.69) compared to those with TTT < 60 days in stage I–III cases. Independent of TTT, CNB was associated with 28% higher risk of BCSM compared to VAB in stage II–III cases (sHR = 1.28, 95% CI 1.11–1.36), translating to a 2.7% and 4.0% absolute difference in BCSM at 5 and 10 years, respectively. However, in stage I cases, the BCSM risk was not associated with type of biopsy. Conclusions: Our results suggest that treatment delay ≥ 60 days is independently associated with poorer survival outcomes in breast cancer patients. In stage II–III, CNB is associated with higher BCSM than VAB. However, type of biopsy does not underlie TTT-associated breast cancer mortality risk. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Association of polypharmacy with incidence of CKD: a retrospective cohort study.
- Author
-
Kimura, Hiroshi, Tanaka, Kenichi, Saito, Hirotaka, Iwasaki, Tsuyoshi, Watanabe, Shuhei, Kazama, Sakumi, Shimabukuro, Michio, Asahi, Koichi, Watanabe, Tsuyoshi, and Kazama, Junichiro James
- Subjects
- *
CHRONIC kidney failure , *POLYPHARMACY , *DISEASE risk factors , *COHORT analysis , *GLOMERULAR filtration rate - Abstract
Background: Polypharmacy is common in patients with chronic kidney disease (CKD) and is associated with a decline in kidney function. However, its impact on patients without CKD has not been adequately elucidated. Therefore, we aimed to investigate the association between polypharmacy and the incidence of CKD. Methods: We conducted retrospective cohort study using 1221 participants who were enrolled in the Fukushima Cohort Study with one or more risk factors of CKD, an estimated glomerular filtration rate (eGFR) of ≥ 60 mL/min/1.73 m2, and without proteinuria. Participants were categorized into three groups based on the number of medications: non-polypharmacy, 0–4 medications; polypharmacy, 5–9 medications; and hyper-polypharmacy, ≥ 10 medications. Results: The median age was 62 years, 49% were men, the median eGFR was 75.4 ml/min/1.73 m2, and the median number of medications was 5. Polypharmacy and hyper-polypharmacy were noted in 506 (41%) and 250 (20%) participants, respectively. During follow-up, 288 participants developed CKD and 67 cardiovascular events were observed. Compared to the non-polypharmacy group, the hyper-polypharmacy group had a higher risk of CKD and cardiovascular events. The adjusted hazard ratios were 1.41 (95% CI1.01–1.99) and 2.24 (95% CI1.05–4.78) for the incidence of CKD and cardiovascular events, respectively. Sensitivity analyses yielded similar findings for the restricted cubic spline function models. Conclusions: Hyper-polypharmacy is associated with a higher risk of CKD and cardiovascular events. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Association between height loss and mortality in the general population.
- Author
-
Iwasaki, Tsuyoshi, Kimura, Hiroshi, Tanaka, Kenichi, Asahi, Koichi, Iseki, Kunitoshi, Moriyama, Toshiki, Yamagata, Kunihiro, Tsuruya, Kazuhiko, Fujimoto, Shouichi, Narita, Ichiei, Konta, Tsuneo, Kondo, Masahide, Kasahara, Masato, Shibagaki, Yugo, Watanabe, Tsuyoshi, and Kazama, Junichiro J.
- Subjects
PROPORTIONAL hazards models ,CARDIOVASCULAR disease related mortality ,VERTEBRAL fractures ,MORTALITY - Abstract
Height loss is caused by osteoporosis, vertebral fractures, disc reduction, postural changes, and kyphosis. Marked long-term height loss is reportedly associated with cardiovascular disease and mortality in the elderly. The present study investigated the relationship between short-term height loss and the risk of mortality using the longitudinal cohort data of the Japan Specific Health Checkup Study (J-SHC). Included individuals were aged 40 years or older and received periodic health checkups in 2008 and 2010. The exposure of interest was height loss over the 2 years, and the outcome was all-cause mortality over subsequent follow up. Cox proportional hazard models were used to examine the association between height loss and all-cause mortality. Of the 222,392 individuals (88,285 men, 134,107 women) included in this study, 1436 died during the observation period (mean 4.8 ± 1.1 years). The subjects were divided into two groups based on a cut-off value of height loss of 0.5 cm over 2 years. The adjusted hazard ratio (95% confidence interval) was 1.26 (1.13–1.41) for exposure to height loss ≥ 0.5 cm compared to height loss < 0.5 cm. Height loss ≥ 0.5 cm correlated significantly with an increased risk of mortality compared to height loss < 0.5 cm in both men and women. Even a small decrease in height over 2 years was associated with the risk of all-cause mortality and might be a helpful marker for stratifying mortality risk. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Possible involvement of CXCR3-CXCR6 + CD4 + T cells in Langerhans cell histiocytosis.
- Author
-
Tokutsu, Akemi, Okada, Yosuke, Kurozumi, Akira, Tanaka, Kenichi, Kubo, Satoshi, and Tanaka, Yoshiya
- Subjects
LANGERHANS-cell histiocytosis ,CD4 antigen ,T cells ,T helper cells ,LANGERHANS cells ,MAGNETIC resonance imaging ,TEMPORAL bone ,INTERLEUKIN receptors - Abstract
Introduction: Langerhans cell histiocytosis (LCH) is a condition characterized by proliferation of Langerhans cells and wide-range pathologies, ranging from single granulomatous lesions to multi-organ involvement, associated with tissue destruction. LCH pathogenesis remains obscure although association with interleukin (IL)-17A has been reported. We report here a case that illustrates the potential pathogenic role of helper T17 (Th17) cells in LCH-related bone destruction. Materials and Methods: The patient was a 66-year-old woman. The clinical course included craniectomy and bone mass excision in X-9, diagnosis of LCH confirmed by histopathology, followed by 26-month chemotherapy. In August X, the patient was diagnosed with complete central diabetes insipidus. Symptoms improved after treatment with desmopressin. Pituitary magnetic resonance imaging showed swelling extending from the suprasellar region to the pituitary stalk, suggestive of LCH recurrence. This was followed by chemotherapy combined with mercaptopurine hydrate. Results: Subsequent peripheral blood lymphocyte analysis showed marked increase in activated Th17 cells (CXCR3
− CXCR6+ CD4+ T cells). Double staining for CD4 and IL-17 by immunofluorescence of pathological tissue samples obtained during temporal bone mass excision, which confirmed the diagnosis of LCH in X-9, showed areas of combined presence of CD4-positive cells and IL-17-positive cells. Chemotherapy resulted in size reduction of the pituitary lesion and decrease in peripheral blood-activated Th17 cells. Conclusions: We found abundant peripheral blood-activated Th17 cells and high percentages of IL-17-producing cells in osteolytic bone lesions in LCH. This finding, together with the decrease in peripheral blood-activated Th17 cells following chemotherapy, suggests the potential involvement of activated Th17 cells in LCH-related osteolysis. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
10. Induction of premature senescence and a less-fibrogenic phenotype by programmed cell death 4 knockdown in the human hepatic stellate cell line Lieming Xu-2.
- Author
-
Perveen, Rasheda, Ozaki, Iwata, Manirujjaman, M., Mine, Keiichiro, Murata, Yuzo, Tanaka, Kenichi, Xia, Jinghe, Takahashi, Hirokazu, Anzai, Keizo, and Matsuhashi, Sachiko
- Subjects
LIVER cells ,APOPTOSIS ,CELL lines ,CELLULAR aging ,PHENOTYPES - Abstract
Although programmed cell death 4 (PDCD4) was initially reported as a tumor suppressor and has been shown to inhibit cancer cell growth and metastasis, recent studies have demonstrated that loss of PDCD4 expression also induces growth inhibition by inducing apoptosis and/or cellular senescence. At present, the roles of PDCD4 in the activation and profibrogenic properties of myofibroblasts, which are critically involved in organ fibrosis, such as that in the liver, are unclear. We, therefore, investigated the roles of PDCD4 in myofibroblasts using human hepatic stellate cell line Lieming Xu-2 (LX-2). PDCD4 knockdown inhibited LX-2 proliferation and induced a senescent phenotype with increased β-galactosidase staining and p21 expression in a p53-independent manner together with downregulation of the notch signaling mediator RBJ-κ/CSL. During PDCD4 knockdown, alpha smooth muscle actin (α-SMA; an activation marker of myofibroblasts), matrix metalloproteinases MMP-1 and MMP-9, and collagen IV were upregulated, but the expression of collagen1α1 and collagen III was markedly downregulated without any marked change in the expression of tissue inhibitor of metalloproteinase-1 (TIMP-1). These results demonstrated that knockdown of PDCD4 induced the cellular senescence phenotype and activated myofibroblasts while suppressing the profibrogenic phenotype, suggesting roles of PDCD4 in cellular senescence and fibrogenesis in the liver. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Hematological parameters of anemia and prognosis of non-dialysis-dependent chronic kidney disease: the Fukushima CKD cohort study.
- Author
-
Saito, Hirotaka, Tanaka, Kenichi, Iwasaki, Tsuyoshi, Oda, Akira, Watanabe, Shuhei, Kobari, Eri, Kimura, Hiroshi, Kazama, Sakumi, Shimabukuro, Michio, Asahi, Koichi, Watanabe, Tsuyoshi, and Kazama, Junichiro J.
- Subjects
- *
CHRONIC kidney failure , *ERYTHROPOIETIN receptors , *ERYTHROCYTES , *COHORT analysis , *ANEMIA , *PROGNOSIS - Abstract
Background: Mean corpuscular volume (MCV) and red cell distribution width (RDW), as well hemoglobin, are reported to be associated with mortality in various populations. However, associations between such hematological parameters and adverse outcomes in patients with CKD have not been sufficiently elucidated. Methods: A total of 1,320 participants enrolled in the Fukushima CKD Cohort Study were examined to investigate associations between hematological parameters of anemia (MCV and RDW) and adverse outcomes, such as ESKD, all-cause death, and cardiovascular events, in patients with non-dialysis-dependent CKD. Baseline hematological parameters were grouped as follows: hemoglobin into 3 categories (< 11.0 g/dL, 11.0 ≤ − < 13.0 g/dL [reference], and ≥ 13.0 g/dL); MCV into 5 categories (< 90 fL, ≥ 90 – < 94 fL [reference], ≥ 94 − < 98 fL, ≥ 98 − < 102 fL, and ≥ 102 fL); and RDW into 2 categories (< 13.6% [reference] vs ≥ 13.6%). Results: During the median observational period of 4.7 years, 120 patients developed ESKD, 160 developed cardiovascular events, and 122 died. Hemoglobin < 11 g/dL (hazard ratio [HR] 1.56, 95% confidence interval [CI], 1.00–2.42), MCV < 90 fL (HR 2.01, 95% CI 1.14–3.54), and RDW ≥ 13.6% (HR 1.57, 95% CI 1.01–2.42) were significantly associated with higher risks of ESKD. Hemoglobin < 11 g/dL, MCV ≥ 98 fL, and RDW ≥ 13.6% were significantly associated with higher risks of all-cause death. No significant associations between hematological parameters and risk of cardiovascular events were confirmed. Conclusion: In patients with non-dialysis-dependent CKD, MCV, RDW, and hemoglobin were associated with increased risks of ESKD and all-cause mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Quantitative [99mTc]Tc-MDP SPECT/CT correlated with [18F]NaF PET/CT for bone metastases in patients with prostate cancer.
- Author
-
Tanaka, Kenichi, Norikane, Takashi, Mitamura, Katsuya, Yamamoto, Yuka, Maeda, Yukito, Fujimoto, Kengo, Takami, Yasukage, Ishimura, Mariko, Arai-Okuda, Hanae, Tohi, Yoichiro, Kudomi, Nobuyuki, Sugimoto, Mikio, and Nishiyama, Yoshihiro
- Subjects
- *
SINGLE-photon emission computed tomography , *POSITRON emission tomography , *PROSTATE cancer patients , *BONE metastasis - Abstract
Background: The purpose of the present study was to elucidate the correlation between standardized uptake value (SUV) and volume-based parameters measured by quantitative [99mTc]Tc-methylene diphosphonate (MDP) single photon emission computed tomography (SPECT)/CT and [18F]-sodium fluoride ([18F]NaF) positron emission tomography (PET)/CT in the assessment of bone metastases in patients with prostate cancer. Methods: The study included 26 male prostate cancer patients with confirmed or suspected bone metastases who underwent both [99mTc]Tc-MDP SPECT/CT and [18F]NaF PET/CT studies. Skeletal lesions visible on both SPECT/CT and PET/CT were classified as benign or metastases. The maximum SUV (SUVmax), peak SUV (SUVpeak), mean SUV (SUVmean), metabolic bone volume (MBV), and total bone uptake (TBU) were calculated for every lesion showing abnormal uptake. Results: A total of 202 skeletal lesions (147 benign and 55 metastases) were detected in the 26 patients. Strong significant correlations were noted between SPECT/CT and PET/CT for the SUV- and volume-based parameters (all P < 0.001). The SUVmax, SUVpeak, SUVmean, and TBU values obtained with SPECT/CT were significantly lower than the corresponding values obtained with PET/CT (all P < 0.001). The MBV in SPECT/CT was significantly higher than that in PET/CT (P < 0.001). All SUV- and volume-based parameters obtained with both SPECT/CT and PET/CT for metastatic lesions were significantly higher than the corresponding parameters for benign lesions (P values from 0.036 to < 0.001). Conclusions: These preliminary results demonstrate that the SUV- and volume-based parameters for bone uptake obtained with quantitative SPECT/CT and PET/CT are strongly correlated in patients with prostate cancer. The SUV parameters obtained with SPECT/CT were significantly lower than those obtained with PET/CT, whereas the uptake volume obtained with SPECT/CT was significantly higher than that obtained with PET/CT. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Possible mechanism for improving the endogenous immune system through the blockade of peripheral μ-opioid receptors by treatment with naldemedine.
- Author
-
Gondoh, Eizoh, Hamada, Yusuke, Mori, Tomohisa, Iwazawa, Yusuke, Shinohara, Asami, Narita, Michiko, Sato, Daisuke, Tezuka, Hiroyuki, Yamauchi, Takayasu, Tsujimura, Mayu, Yoshida, Sara, Tanaka, Kenichi, Yamashita, Kensuke, Akatori, Haruka, Higashiyama, Kimio, Arakawa, Kazuhiko, Suda, Yukari, Miyano, Kanako, Iseki, Masako, and Inada, Eiichi
- Subjects
NALTREXONE ,OPIOID receptors ,IMMUNE system ,MORPHINE ,RESEARCH funding ,TUMORS ,OPIOID analgesics ,ANIMALS ,MICE ,CHEMICAL inhibitors - Abstract
Background: It has been considered that activation of peripheral μ-opioid receptors (MORs) induces side effects of opioids. In this study, we investigated the possible improvement of the immune system in tumour-bearing mice by systemic administration of the peripheral MOR antagonist naldemedine.Methods: The inhibitory effect of naldemedine on MOR-mediated signalling was tested by cAMP inhibition and β-arrestin recruitment assays using cultured cells. We assessed possible changes in tumour progression and the number of splenic lymphocytes in tumour-bearing mice under the repeated oral administration of naldemedine.Results: Treatment with naldemedine produced a dose-dependent inhibition of both the decrease in the cAMP level and the increase in β-arrestin recruitment induced by the MOR agonists. Repeated treatment with naldemedine at a dose that reversed the morphine-induced inhibition of gastrointestinal transport, but not antinociception, significantly decreased tumour volume and prolonged survival in tumour-transplanted mice. Naldemedine administration significantly decreased the increased expression of immune checkpoint-related genes and recovered the decreased level of toll-like receptor 4 in splenic lymphocytes in tumour-bearing mice.Conclusions: The blockade of peripheral MOR may induce an anti-tumour effect through the recovery of T-cell exhaustion and promotion of the tumour-killing system. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
14. A comparison of the ClotPro system with rotational thromboelastometry in cardiac surgery: a prospective observational study.
- Author
-
Yoshii, Ryogo, Sawa, Teiji, Kawajiri, Hidetake, Amaya, Fumimasa, Tanaka, Kenichi A., and Ogawa, Satoru
- Subjects
CARDIAC surgery ,BLOOD coagulation factor XIII ,PEARSON correlation (Statistics) ,THROMBELASTOGRAPHY ,CARDIOPULMONARY bypass ,LONGITUDINAL method - Abstract
Viscoelastic coagulation tests have been increasingly used for hemostasis management in cardiac surgery. The ClotPro system is a novel viscoelastic device based on principles of rotational thromboelastometry. We aimed to compare ClotPro with ROTEM and plasma coagulation assays in cardiopulmonary bypass (CPB) patients. Blood samples were collected from 25 CPB patients at (1) baseline, (2) start of CPB, (3) end of CPB, and (4) end of surgery. The EX-test, IN-test, HI-test, FIB-test parameters on ClotPro were compared with corresponding ROTEM assay (EXTEM, INTEM, HEPTEM, and FIBTEM). Standard plasma coagulation assays and endogenous thrombin generation (TG) were simultaneously evaluated. Pearson correlation analyses showed moderate correlations between clotting times (CTs) (r = 0.63–0.67; p < 0.001, respectively), and strong correlations with maximal clot firmness (MCF) (r = 0.93–0.98; p < 0.001, respectively) between ClotPro and ROTEM. EX-test and IN-test MCF parameters were interchangeable with acceptable percentage errors (EX-test MCF: 7.3%, IN-test MCF: 8.3%), but FIB-test MCF (27.0%) and CT results were not (EX-test CT: 44.7%, IN-test CT: 31.4%). The correlations of PT/INR or peak TG with EX-test CTs were higher than with EXTEM CTs (PT/INR: r = 0.80 and 0.41, peak TG: 0.43 and 0.18, respectively). FIB-test MCF has strong correlation with plasma fibrinogen and factor XIII level (r = 0.84 and 0.66, respectively). ROC analyses showed that ClotPro was capable of emulating well-established ROTEM thresholds (area under curves: 0.83–1.00). ClotPro demonstrated strong correlations in MCF parameters of ROTEM in CPB patients. It may be reasonable to modify ROTEM-based transfusion algorithm pertaining to MCF parameters to establish cut-off values for ClotPro device. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Efficacy of sonorheometry point of the care device in determining low fibrinogen levels in pregnant blood: an invitro dilution and reconstitution study.
- Author
-
Kodali, Bhavani Shankar, Karuppiah, Arun, Bharadwaj, Shobana, Chow, Jonathan, and Tanaka, Kenichi
- Abstract
Quantra® Hemostasis Analyzer is a Point of the care device that uses ultrasound technology to assess clot formation. In this study, we establish how Quantra® system performs compared to conventional coagulation tests at low levels of fibrinogen in the blood obtained from pregnant women. 24 mL blood was obtained from each healthy parturient. Blood was analyzed for Quantra® variables (Q): Clot time (CT), Clot stiffness (CS), platelet contribution to CS (PCS), fibrinogen contribution to CS (FCS), and conventional coagulation (CL) tests: PT, aPTT, INR, Factor VIII and fibrinogen. 6 ml blood were centrifuged to obtain pregnant plasma. 30 mL of saline was added to 10 mL of blood to simulate crystalloid resuscitation (DB) and was evaluated for Q and CL. Fractions of pregnant plasma, or nonpregnant plasma (Blood Bank) was added to DB to obtain 15% and 30% clotting factor enriched samples. 4 ml of DB was added to 4 ml of original blood (1:1) to obtain the final sample (resus). Each of the samples were analyzed for Q and CL parameters. Regression analysis and Receiving Characteristics Curves were used to study the relationship between Quantra variables and CL tests. There were remarkably high linear correlations between Fibrinogen and CS (R = 0.93, P < 0.001), fibrinogen and FCS (R = 0.77, P < 0.001). An FCS value 2.45 (sensitivity of 79.2 and specificity of 97.3%), and CS value 10.85 hPa (sensitivity of 83% and specificity of 100%) predicted fibrinogen of 200 mg/dL. This study demonstrates a good correlation between Quantra® CS, FCS and serum fibrinogen. Clinical Trial Number: NCT04301193. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Impact of lifestyle and psychosocial factors on the onset of hypertension after the Great East Japan earthquake: a 7-year follow-up of the Fukushima Health Management Survey.
- Author
-
Kobari, Eri, Tanaka, Kenichi, Nagao, Masanori, Okazaki, Kanako, Hayashi, Fumikazu, Kazama, Sakumi, Ohira, Tetsuya, Yasumura, Seiji, Shimabukuro, Michio, Maeda, Masaharu, Sakai, Akira, Yabe, Hirooki, Hosoya, Mitsuaki, Takahashi, Atsushi, Harigane, Mayumi, Ohto, Hitoshi, Kamiya, Kenji, and Kazama, Junichiro James
- Published
- 2022
- Full Text
- View/download PDF
17. Health-related behavioral changes and incidence of chronic kidney disease: The Japan Specific Health Checkups (J-SHC) Study.
- Author
-
Kimura, Hiroshi, Asahi, Koichi, Tanaka, Kenichi, Iseki, Kunitoshi, Moriyama, Toshiki, Yamagata, Kunihiro, Tsuruya, Kazuhiko, Fujimoto, Shouichi, Narita, Ichiei, Konta, Tsuneo, Kondo, Masahide, Kasahara, Masato, Shibagaki, Yugo, Watanabe, Tsuyoshi, and Kazama, Junichiro J.
- Subjects
CHRONIC kidney failure ,LOGISTIC regression analysis ,JAPANESE people ,HEALTH behavior - Abstract
The transtheoretical model (TTM) is a commonly used model of health-related behavioral change. However, the practical effect of using this model for chronic kidney disease (CKD) self-management remains unclear. This study aimed to investigate the association between stages of change for lifestyle behavior and the incidence of CKD in the general Japanese population. A retrospective cohort study was conducted among 178,780 non-CKD participants aged 40–74 years who underwent annual health check-ups for two consecutive years between 2008 and 2009. Health behavior change was determined using questionnaires based on the TTM, which consists of five stages of change (precontemplation, contemplation, preparation, action, and maintenance). The exposure of interest was the change in stages between two years. Participants were categorized into 3 groups 'improved', 'unchanged', or 'deteriorated'. The association between the change in stages and the incidence of CKD was examined using logistic regression analysis. After one year of follow-up, 20.0% of participants developed CKD. Participants in the deteriorated group showed a significantly higher risk of CKD incidence than in the improved group. Promoting the stage of change for healthy lifestyle behaviors evaluated by the TTM was associated with a risk reduction for the incidence of CKD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Coagulation Management in End-Stage Liver Disease.
- Author
-
Shettar, Shashank S., Vandyck, Kofi, and Tanaka, Kenichi A.
- Published
- 2022
- Full Text
- View/download PDF
19. Thrombin Generation in Trauma Patients: How Do we Navigate Through Scylla and Charybdis?
- Author
-
Mitrophanov, Alexander Y., Vandyck, Kofi, and Tanaka, Kenichi A.
- Published
- 2022
- Full Text
- View/download PDF
20. Hypoglycemia induces vascular endothelial dysfunction in subjects with normal glucose tolerance.
- Author
-
Tanaka, Kenichi, Okada, Yosuke, Torimoto, Keiichi, Nishio, Kosuke, Narisawa, Manabu, and Tanaka, Yoshiya
- Subjects
- *
ENDOTHELIUM diseases , *HYPOGLYCEMIA , *INSULIN resistance , *SYSTOLIC blood pressure , *GLUCOSE intolerance , *INSULIN , *DOPAMINE - Abstract
This prospective study determined the effects of hypoglycemic stimulation on vascular endothelial function in non-diabetic patients using reactive hyperemia peripheral arterial tonometry (RH-PAT). The study included non-diabetic patients who were hospitalized for an insulin tolerance test (ITT) for the diagnosis of hypoadrenocorticism or hypopituitarism. Vascular endothelial function was assessed using the reactive hyperemia index (RHI) measured by the RH-PAT. We also measured the levels of anterior pituitary hormone, adrenaline, noradrenaline, and dopamine at the time of hypoglycemia. The primary endpoint was a change in the RHI at 120 min after insulin administration. The study included 27 patients. ITT was associated with significant increases in systolic blood pressure, pulse rate, and the blood levels of adrenocorticotropic hormone, cortisol, growth hormone, adrenaline, noradrenaline, and dopamine. RHI significantly decreased after ITT from 2.24 ± 0.51 to 1.71 ± 0.42. A significant inverse correlation was observed between the change in RHI and change in adrenaline (r = − 0.670, p = 0.012). We concluded that hypoglycemic stimulation altered vascular endothelial function, as measured by RH-PAT, even in patients free of glucose intolerance. The observed deterioration in vascular endothelial function correlated with increases in catecholamine levels during hypoglycemia. Trial registration: UMIN000033244. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
21. Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study.
- Author
-
Tanaka, Kenichi, Okada, Yosuke, Tokutsu, Akemi, and Tanaka, Yoshiya
- Subjects
- *
TYPE 2 diabetes , *JAPANESE people , *PEPTIDE receptors , *LIRAGLUTIDE , *GLUCAGON-like peptide 1 , *GLYCOSYLATED hemoglobin - Abstract
Real-world data comparing the effectiveness of various glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in type 2 diabetes mellitus (T2DM) are limited. We investigated the clinical effectiveness of liraglutide and dulaglutide in Japanese T2DM in a real-world setting. This retrospective study included 179 patients with T2DM who were treated with GLP-1 RA for at least 12 months (liraglutide, n = 97; dulaglutide, n = 82). We used stabilized propensity score-based inverse probability of treatment weighting (IPTW) to reduce selection bias and confounding by observed covariates. Changes in glycated hemoglobin (HbA1c) at the end of the 12-month treatment were evaluated. After adjustment by stabilized propensity score-based IPTW, no significant differences were observed in patient characteristics between the liraglutide and dulaglutide groups. HbA1c was significantly lower at 12 months in both groups (liraglutide, 8.9 to 7.4%; dulaglutide, 8.7 to 7.5%). Multivariate linear regression analysis showed no differences in the extent of changes in HbA1c at 12 months between the two agents. High baseline HbA1c, the addition of GLP-1 RA treatment modality, and in-hospital initiation of GLP-1 RA treatment were identified as significant contributing factors to HbA1c reduction. The effects of liraglutide and dulaglutide on lowering HbA1c levels at 12 months were comparable in a real-world setting. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
22. A case of peripancreatic plexiform schwannoma.
- Author
-
Fukushima, Kenji, Shinzeki, Makoto, Tai, Kentaro, Omori, Masaki, Yamauchi, Natsuko, Tanaka, Tomoko, Matsuda, Yasunori, Ashitani, Hiroshi, and Tanaka, Kenichi
- Subjects
PANCREATIC tumors ,COMPUTED tomography ,ENDOSCOPIC ultrasonography ,PANCREATIC duct ,MAGNETIC resonance imaging ,TYPE 1 diabetes - Abstract
Background: Plexiform schwannoma is one of the least common variants of schwannoma, accounting for only 5% of all schwannoma cases. It generally occurs in the skin and subcutaneous tissues and is uncommon in deep soft tissue or viscera. We present an extremely rare case of plexiform schwannoma arising from the peripancreatic plexus. Case presentation: A 29-year-old man presented with hyperglycemia detected during a medical checkup. He was diagnosed with type 1 diabetes based on the clinical findings and laboratory tests. During the diagnostic process for diabetes, a 2.5 cm mass was incidentally detected in the pancreas by abdominal ultrasound. Contrast-enhanced computed tomography revealed a mass that was gradually enhanced at the body and tail of the pancreas. Magnetic resonance imaging revealed low signal intensity of the mass on T1-weighted images and high signal intensity on T2-weighted and diffusion-weighted images. Magnetic resonance cholangiopancreatography showed no abnormal findings in the main pancreatic duct. Endoscopic ultrasonography (EUS) showed a lobulated, low-echoic mass with a clear boundary. EUS-guided fine needle biopsy was performed, and spindle-shaped cells that were diffusely immunopositive for S-100 and negative for c-kit and desmin were detected, resulting in a diagnosis of a neurogenic tumor arising from the pancreas or the peripancreatic nerve plexus. The patient underwent laparoscopic spleen-preserving distal pancreatectomy. Although the tumor was connected to the splenic plexus, the splenic artery could be divided along its adventitial plane. Macroscopic findings of the excised tumor consisted of multiple yellowish-white nodules, and its histopathological features were consistent with plexiform schwannoma. There was no pancreatic tissue on the dorsal surface of the tumor, which suggested that the tumor arose from the peripancreatic nerve plexus. Conclusions: The findings documented herein can aid in the differential diagnosis of peripancreatic schwannoma and in planning appropriate treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Effect of skin–capsular distance on controlled attenuation parameter for diagnosing liver steatosis in patients with nonalcoholic fatty liver disease.
- Author
-
Kimura, Syunichiro, Tanaka, Kenichi, Oeda, Satoshi, Inoue, Kaori, Inadomi, Chika, Kubotsu, Yoshihito, Yoshioka, Wataru, Okada, Michiaki, Isoda, Hiroshi, Kuwashiro, Takuya, Akiyama, Takumi, Kurashige, Aya, Oshima, Ayaka, Oshima, Mayumi, Matsumoto, Yasue, Kawaguchi, Atsushi, Anzai, Keizo, Sueoka, Eisaburo, Aishima, Shinichi, and Takahashi, Hirokazu
- Subjects
- *
FATTY degeneration , *NON-alcoholic fatty liver disease , *SERUM albumin , *MULTIPLE regression analysis , *MULTIVARIATE analysis - Abstract
The effect of the skin–capsular distance (SCD) on the controlled attenuation parameter (CAP) for diagnosis of liver steatosis in patients with nonalcoholic fatty liver disease (NAFLD) remains unclear. The SCD was measured using B-mode ultrasound, and the CAP was measured using the M probe of FibroScan®. According to the indications of the M probe, 113 patients with an SCD of ≤ 25 mm were included in the present study. The association between the SCD and CAP was investigated, and the diagnostic performance of the SCD-adjusted CAP was tested. The SCD showed the most significant positive correlation with the CAP (ρ = 0.329, p < 0.001). In the multiple regression analysis, the SCD and serum albumin concentration were associated with the CAP, independent of pathological liver steatosis. According to the multivariate analysis, two different formulas were developed to obtain the adjusted CAP using the SCD and serum albumin concentration as follows: adjusted CAP (dB/m) = CAP − (5.26 × SCD) and adjusted CAP (dB/m) = CAP − (5.35 × SCD) − (25.77 × serum albumin concentration). The area under the receiver operating characteristic curve for diagnosis of a steatosis score ≥ 2 of adjusted CAP was 0.678 and 0.684 respectively, which were significantly greater than the original CAP (0.621: p = 0.030 and p = 0.024). The SCD is associated with the CAP independent of liver steatosis. Adjustment of the CAP using the SCD improves the diagnostic performance of the CAP in NAFLD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. 6p.21 translocation renal cell carcinoma in the elderly: radiological findings mimicking fat poor angiomyolipoma or papillary renal cell carcinoma.
- Author
-
Tohi, Yoichiro, Harada, Satoshi, Kuroda, Naoto, Tanaka, Kenichi, Inoue, Kosuke, Kadota, Kyuichi, Haba, Reiji, Nishiyama, Yoshihiro, Ueda, Nobufumi, and Sugimoto, Mikio
- Published
- 2021
- Full Text
- View/download PDF
25. Dry Etching Damage and Alloy Composition Analysis of GaN-Based Semiconductors Using Electron Energy-Loss Spectroscopy.
- Author
-
Yamamoto, Hiroto, Tanaka, Kenichi, Tomiya, Shigetaka, Yamashita, Shunsuke, Ukita, Masakazu, Nakano, Hiroshi, Shirasawa, Raku, Kotera, Masaaki, and Funatsu, Kimito
- Subjects
PLASMA etching ,ELECTRON spectroscopy ,ALLOY analysis ,TRANSMISSION electron microscopes ,SEMICONDUCTORS ,QUANTUM wells - Abstract
Dry etching damage and compositional fluctuation of GaN-based semiconductors and alloys are major issues to overcome to improve device fabrication processes and performance. Electron energy-loss spectroscopy (EELS) in a transmission electron microscope is a useful method for studying these phenomena because it can analyze the elemental composition and chemical bond states of a sample with high spatial resolution. However, because these various components of information are superposed in an EELS spectrum, the analysis has to be performed carefully. This requires multivariate statistical techniques, such as principal component analysis (PCA), to process the large amounts of data extracted from EELS. Herein we apply PCA to N-K core and In-M
4,5 core edge EELS spectra to study the degree of ion-beam etching damage of GaN and the composition of GaInN ternary alloy quantum wells. Two data pretreatment procedures prior to the PCA analysis were examined to assess their comparative practical usefulness. The differential-based pretreatment method for PCA was useful when the shape of the EELS core edge structure was changed, whereas the power-law subtraction-based pretreatment method was useful when the intensity of the EELS core edge structure was variable. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
26. High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes.
- Author
-
Saito, Haruka, Tanabe, Hayato, Kudo, Akihiro, Machii, Noritaka, Higa, Moritake, Yamaguchi, Satoshi, Maimaituxun, Gulinu, Abe, Kazumichi, Takahashi, Atsushi, Tanaka, Kenichi, Asahi, Koichi, Masuzaki, Hiroaki, Ohira, Hiromasa, Kazama, Junichiro J., and Shimabukuro, Michio
- Subjects
TYPE 2 diabetes complications ,FATTY liver ,CHRONIC kidney failure ,HEPATIC fibrosis ,GLOMERULAR filtration rate - Abstract
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) may be linked to development of chronic kidney diseases (CKD). The FIB4 index, a noninvasive liver fibrosis score, has been reported to predict CKD in non-diabetic patients, but there are no reports yet in diabetic cases. Therefore, we evaluated the prognostic impact of FIB4 index on the risk of developing diabetic kidney disease (DKD) in Japanese patients with type 2 diabetes in a retrospective cohort study. We assessed patients with type 2 diabetes with an eGFR ≥ 60 mL/min/1.73 m
2 and without dipstick positive proteinuria (≥ 1 +) at their first visit to our department. Participants were divided into two groups based on the FIB4 index at their first visit: FIB4 index > 1.3 and FIB4 index ≤ 1.3. The primary endpoint was defined as a decrease in eGFR < 60 mL/min/1.73 m2 or the onset of proteinuria during the course of treatment. The average age of all 584 type 2 diabetic participants (360 [61.6%] men) was 55 ± 11 years. There were 187 patients in the FIB4 index group > 1.3 (32.0%) and the median observation period was 6.0 (3.8–11.0) years. Kaplan–Meier survival analysis indicated that the risks of developing DKD, eGFR < 60 and proteinuria were all higher in FIB4 index > 1.3 patients than in FIB4 ≤ 1.3 patients. In the Cox regression analysis, an FIB4 index > 1.3 was a significant predictor for onset of DKD (HR 1.54, 95% CI 1.15–2.08) and proteinuria (HR 1.55, 95% CI 1.08–2.23), but not for an eGFR < 60 (HR 1.14, 95% CI 0.79–1.99). To the best of our knowledge, this is the first study to demonstrate that an FIB4 index > 1.3 has a prognostic impact on the development of CKD and proteinuria in type 2 diabetic patients. This warrants further investigation of the prognostic impact of the development of DKD or proteinuria. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
27. Correlation of 4′-[methyl-11C]-thiothymidine PET with Gd-enhanced and FLAIR MRI in patients with newly diagnosed glioma.
- Author
-
Norikane, Takashi, Mitamura, Katsuya, Yamamoto, Yuka, Maeda, Yukito, Tanaka, Kenichi, Hatakeyama, Tetsuhiro, Miyake, Keisuke, Toyohara, Jun, and Nishiyama, Yoshihiro
- Subjects
POSITRON emission tomography ,GLIOMAS ,DIFFUSION magnetic resonance imaging ,MAGNETIC resonance imaging ,ASTROCYTOMAS - Abstract
Purpose: To elucidate the biological association between tumor proliferation, tumor infiltration and neovascularization, we analyzed the association between volumetric information of 4′-[methyl-
11 C]thiothymidine (4DST) positron emission tomography (PET) and fluid-attenuated inversion recovery (FLAIR) and T1-weighted gadopentetate dimeglumine (Gd)-enhanced magnetic resonance imaging (MRI), in patients with newly diagnosed glioma. Methods: A total of 23 patients with newly diagnosed glioma who underwent both 4DST PET/CT and Gd-enhanced MRI before therapy were available for a retrospective analysis of prospectively collected data. The maximum standardized uptake value (SUVmax) for tumor (T) and the mean SUV for normal contralateral hemisphere (N) were calculated, and the tumor-to-normal (T/N) ratio was determined. Proliferative tumor volume (PTV) from 4DST PET and the volume of Gd enhancement (GdV) and hyperintense region on FLAIR (FLAIRV) from MRI were calculated. Results: All gliomas but 3 diffuse astrocytomas and one anaplastic astrocytoma had 4DST uptake and Gd enhancement on MRI. There was no significant difference between PTV and GdV although the exact edges of the tumor differed in each modality. The FLAIRV was significantly larger than PTV (P < 0.001). Significant correlations between PTV and GdV (ρ = 0.941, P < 0.001) and FLAIRV (ρ = 0.682, P < 0.001) were found. Conclusion: These preliminary results indicate that tumor proliferation assessed by 4DST PET is closely associated with tumor-induced neovascularization determined by Gd-enhanced MRI in patients with newly diagnosed glioma. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
28. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
- Author
-
Tanaka, Kenichi, Saito, Hirotaka, Iwasaki, Tsuyoshi, Oda, Akira, Watanabe, Shuhei, Kanno, Makoto, Kimura, Hiroshi, Shimabukuro, Michio, Asahi, Koichi, Watanabe, Tsuyoshi, and Kazama, Junichiro J.
- Subjects
- *
CHRONIC kidney failure , *POTASSIUM , *COHORT analysis , *JAPANESE people , *HYPOKALEMIA - Abstract
Background: Serum potassium disorders, commonly observed in chronic kidney disease (CKD), are reportedly associated with higher mortality, but their impact on renal outcomes is still controversial. Methods: The present study used the longitudinal data of the Fukushima CKD cohort study to investigate the relationships between hypokalemia and hyperkalemia and adverse outcomes such as renal outcomes and all-cause mortality in Japanese patients with non-dialysis-dependent CKD. The study involved 1330 CKD patients followed-up for 2.8 years. The primary endpoint of the present study was a kidney event, defined as a combination of doubling of baseline serum creatinine and end-stage kidney disease. Results: Hyperkalemia (≥ 5.0 mmol/L) was noted in 10.6% and hypokalemia (< 4.0 mmol/L) in 16.4% of the study population. Significant U-shaped associations were observed between potassium levels and both kidney events and all-cause mortality on univariate Cox regression analyses. After adjustment for covariates, both hypokalemia and hyperkalemia were significantly associated with an increased risk of kidney events, with the lowest risk at a serum potassium of 4.0–4.4 mmol/L. Compared with a reference level of 4.0–4.4 mmol/L, the adjusted hazard ratio for kidney events was 2.49 (1.33–4.66) for serum potassium < 4.0 mmol/L, 1.72 (1.00–2.96) for 4.5–4.9 mmol/L, and 2.16 (1.15–4.06) for ≥ 5.0 mmol/L. There was no significant association between serum potassium levels and mortality after multivariate adjustment. Conclusion: Hypokalemia and hyperkalemia were associated with an increased risk of CKD progression, but not with mortality in Japanese patients with non-dialysis-dependent CKD. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
29. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040.
- Author
-
Ito, Takanori, Ishigami, Masatoshi, Zou, Biyao, Tanaka, Taku, Takahashi, Hirokazu, Kurosaki, Masayuki, Maeda, Mayumi, Thin, Khin Naing, Tanaka, Kenichi, Takahashi, Yuka, Itoh, Yoshito, Oniki, Kentaro, Seko, Yuya, Saruwatari, Junji, Kawanaka, Miwa, Atsukawa, Masanori, Hyogo, Hideyuki, Ono, Masafumi, Ogawa, Eiichi, and Barnett, Scott D.
- Abstract
Background: NAFLD is increasing in Asia including Japan, despite its lower obesity rate than the West. However, NAFLD can occur in lean people, but data are limited. We aimed to investigate the epidemiology of NAFLD in Japan with a focus on lean NAFLD. Methods: We searched PubMed, Cochrane Library, EMBASE, Web of Science, and the Japan Medical Abstracts Society (inception to 5/15/2019) and included 73 eligible full-text original research studies (n = 258,531). We used random-effects model for pooled estimates, Bayesian modeling for trend and forecasting, contacted authors for individual patient data and analyzed 14,887 (7752 NAFLD; 7135 non-NAFLD—8 studies) patients. Results: The overall NAFLD prevalence was 25.5%, higher in males (p < 0.001), varied by regions (p < 0.001), and increased over time (p = 0.015), but not by per-person income or gross prefectural productivity, which increased by 0.64% per year (1983–2012) and is forecasted to reach 39.3% in 2030 and 44.8% in 2040. The incidence of NAFLD, HCC, and overall mortality were 23.5, 7.6 and 5.9 per 1000 person-years, respectively. Individual patient-level data showed a lean NAFLD prevalence of 20.7% among the NAFLD population, with lean NAFLD persons being older and with a higher all-cause mortality rate (8.3 vs. 5.6 per 1000 person-years for non-lean NAFLD, p = 0.02). Older age, male sex, diabetes, and FIB-4 were independent predictors of mortality, but not lean NAFLD. Conclusion: NAFLD prevalence has increased in Japan and may affect half of the population by 2040. Lean NAFLD individuals makeup 20% of the NAFLD population, were older, and had higher mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
30. Cardiac sympathetic denervation in coronary artery fistula.
- Author
-
Mitamura, Katsuya, Norikane, Takashi, Tanaka, Kenichi, Arai-Okuda, Hanae, Takami, Yasukage, Yamamoto, Yuka, Matsumoto, Keisuke, and Nishiyama, Yoshihiro
- Published
- 2022
- Full Text
- View/download PDF
31. Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease.
- Author
-
Saito, Hirotaka, Tanaka, Kenichi, Iwasaki, Tsuyoshi, Oda, Akira, Watanabe, Shuhei, Kanno, Makoto, Kimura, Hiroshi, Shimabukuro, Michio, Asahi, Koichi, Watanabe, Tsuyoshi, and Kazama, Junichiro James
- Subjects
- *
XANTHINE oxidase , *ENZYME inhibitors , *CARDIOVASCULAR diseases risk factors , *HYPERURICEMIA , *CHRONIC kidney failure - Abstract
As previous studies have reported finding an association between hyperuricemia and the development of cardiovascular and chronic kidney disease, hyperuricemia is thought to be an independent risk factor for hypertension and diabetic mellitus. However, we have not been able to determine whether the use of xanthine oxidase inhibitors can reduce cardiovascular disease. The present study used the longitudinal data of the Fukushima Cohort Study to investigate the relationship between the use of xanthine oxidase inhibitors and cardiovascular events in patients with cardiovascular risks. During the 3-year period between 2012 and 2014, a total of 2724 subjects were enrolled in the study and followed. A total of 2501 subjects had hypertension, diabetic mellitus, dyslipidemia, or chronic kidney disease, and were identified as having cardiovascular risks. The effects of xanthine oxidase inhibitor use on the development of cardiovascular events was evaluated in these patients using a time to event analysis. During the observational periods (median 2.7 years), the incidence of cardiovascular events was 20.7 in subjects with xanthine oxidase inhibitor and 11.2 (/1000 person-years, respectively) in those without. Although a univariate Cox regression analysis showed that the risk of cardiovascular events was significantly higher in subjects administered xanthine oxidase inhibitors (HR = 1.87, 95% CI 1.19–2.94, p = 0.007), the risk was significantly lower in subjects administered a xanthine oxidase inhibitor after adjustment for covariates (HR = 0.48, 95% CI 0.26–0.91; p = 0.024) compared to those without. Xanthine oxidase inhibitor use was associated with reduced risk of cardiovascular disease in patients with cardiovascular risk factors. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
32. FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients.
- Author
-
Kawata, Nozomi, Takahashi, Hirokazu, Iwane, Shinji, Inoue, Kanako, Kojima, Motoyasu, Kohno, Michiko, Tanaka, Kenichi, Mori, Hitoe, Isoda, Hiroshi, Oeda, Satoshi, Matsuda, Yayoi, Egashira, Yoshiaki, Nojiri, Jyunichi, Irie, Hiroyuki, Eguchi, Yuichiro, and Anzai, Keizo
- Abstract
Liver fibrosis is associated with lifestyle-related diseases, including diabetes. The identification of diabetic patients with severe liver fibrosis is important, but a simple and reliable diagnostic procedure remains to be determined. We conducted an observational study to evaluate the performance of a FIB-4 index-based screening strategy for the diagnosis of advanced liver fibrosis in patients with diabetes or prediabetes. Two hundred and forty-two patients underwent abdominal imaging in our Study. According to the abdominal imaging findings, fatty liver, liver cirrhosis, and hepatocellular carcinoma were defined, and their association with FIB-4 index evaluated. The prevalences of liver cirrhosis and hepatocellular carcinoma in patients with a high (≥ 2.67; liver cirrhosis: 42.9%, hepatocellular carcinoma: 14.3%) FIB-4 index were significantly higher than in those with an intermediate (1.3 ≤ FIB-4 < 2.67; liver cirrhosis: 1.6%, hepatocellular carcinoma: 0.8%) or low FIB-4 index (< 1.3; liver cirrhosis: 1.2%, hepatocellular carcinoma: 0%). The diagnostic accuracy, specificity, and sensitivity of the FIB-4 index for the diagnosis of liver cirrhosis or hepatocellular carcinoma were 84.3%, 85.5%, and 89.3%, respectively, with an optimized cut-off value of 2.96 (sensitivity = 0.86, specificity = 0.98). Using an optimized cut-off value, FIB-4 index might be useful to identify liver cirrhosis or hepatocellular carcinoma in diabetes patients with high diagnostic accuracy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
33. Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis.
- Author
-
Iguchi, Akira, Yamamoto, Suguru, Oda, Akira, Tanaka, Kenichi, Kazama, Junichiro James, Saeki, Takako, Yamazaki, Hajime, Ishioka, Ken, Suzutani, Tatsuo, and Narita, Ichiei
- Subjects
CHRONIC kidney failure ,CHRONICALLY ill ,TOXINS ,HEMODIALYSIS patients ,HEMODIAFILTRATION ,GASTROINTESTINAL surgery - Abstract
Background: In patients with chronic kidney disease (CKD), dysbiosis in the gastrointestinal microbiome is thought to be associated with increased production of uremic toxins, such as indoxyl sulfate (IS) and p-cresyl sulfate (PCS). Sucroferric oxyhydroxide (SFO), an iron-based phosphate binder, may affect the gastrointestinal microbiome and the production of uremic toxins. We aimed to examine whether SFO administration affected distribution of gastrointestinal microbiome and serum uremic toxin levels in CKD patients undergoing hemodialysis. Methods: In this single-center, open-label, interventional study, 18 maintenance hemodialysis patients with hyperphosphatemia were prescribed with SFO. We collected serum samples before and after 3 months of administration, and serum levels of IS and PCS were measured. A control group of 20 hemodialysis patients without SFO was evaluated. We evaluated gastrointestinal microbiome of patients pre- and post-SFO administration by 16S rDNA sequencing and bioinformatics analysis. Results: Serum IS and PCS levels were significantly elevated after administration of SFO (IS before 2.52 ± 1.60 mg/dl vs. after 3.13 ± 1.51 mg/dl, P = 0.008; PCS before 2.32 ± 2.44 mg/dl vs. after 3.45 ± 2.11 mg/dl, P = 0.002), while serum IS and PCS levels did not change in the control group. Microbiome analysis in the SFO group showed no significant change in diversity and major components in phylum, class, order, family, gene, and species. Conclusion: Administration of SFO increased the serum levels of IS and PCS with no change of major components of gastrointestinal microbiome. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
34. Blood pressure control in chronic kidney disease according to underlying renal disease: the Fukushima CKD cohort.
- Author
-
Nakajima, Aya, Tanaka, Kenichi, Saito, Hirotaka, Iwasaki, Tsuyoshi, Oda, Akira, Kanno, Makoto, Shimabukuro, Michio, Asahi, Koichi, Watanabe, Tsuyoshi, and Kazama, Junichiro James
- Subjects
- *
KIDNEY diseases , *BLOOD pressure , *CHRONIC kidney failure , *DIABETIC nephropathies , *SYSTOLIC blood pressure , *HYPOTENSION - Abstract
Background: Inadequate blood pressure control is one of the important causes of chronic kidney disease (CKD), but only a limited number of reports have examined blood pressure control in Japanese patients with pre-dialysis CKD. Differences in blood pressure control due to underlying renal disease in pre-dialysis patients with CKD were investigated in the present study using the baseline data of the Fukushima CKD cohort study. Methods: The study involved 1351 CKD patients, classified by underlying disease of primary renal disease, hypertensive nephropathy, diabetic nephropathy, other nephropathies, or unknown. Target blood pressure of CKD patients was defined as < 130/80 mmHg in patients under 75 years old with diabetes and/or proteinuria, and < 140/90 mmHg in other patients. Results: The achievement rate of target systolic blood pressure was lower in the diabetic and hypertensive nephropathy groups than in the primary renal disease group (33.3%, 46.0% vs. 68.1%, p < 0.001). However, the number of antihypertensive medications increased in the diabetic and hypertensive nephropathy groups compared to the primary renal disease group (2.16, 2.04 vs. 1.55, p < 0.001). Inadequate blood pressure control was independently related to the underlying renal disease, with a significant difference between diabetic nephropathy and primary renal disease (odds ratio 3.19; 95% confidence interval, 2.16–4.69; p < 0.001). Conclusion: This study showed that blood pressure control differs by the underlying renal disease. Blood pressure control was poor especially in diabetic nephropathy despite multidrug combination antihypertensive treatment. It is necessary to verify whether strict blood pressure control improves patients' prognosis in diabetic nephropathy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
35. Regional 18F-FDG uptake indicates coronary artery anomaly in a middle-aged patient with no atherosclerosis risk.
- Author
-
Norikane, Takashi, Ihara, Ayumi, Yamamoto, Yuka, Takami, Yasukage, Mitamura, Katsuya, Tanaka, Kenichi, Arai-Okuda, Hanae, and Nishiyama, Yoshihiro
- Abstract
Regional 18F-FDG uptake indicates coronary artery anomaly in a middle-aged patient with no atherosclerosis risk Initially, she was suspected of having cardiac sarcoidosis and then SP 18 sp F-FDG positron emission tomography (PET)/computed tomography (CT) was performed. Arrows (A and B) show the left coronary artery stenosis between the aorta and pulmonary artery Graph: Figure 3 Stress/redistribution 201Tl SPECT and quantitative perfusion SPECT images. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
36. Comparison and improvement of the predictability and interpretability with ensemble learning models in QSPR applications.
- Author
-
Chen, Chia-Hsiu, Tanaka, Kenichi, Kotera, Masaaki, and Funatsu, Kimito
- Subjects
- *
FEATURE selection , *STRUCTURE-activity relationships , *FORECASTING , *MACHINE learning - Abstract
Ensemble learning helps improve machine learning results by combining several models and allows the production of better predictive performance compared to a single model. It also benefits and accelerates the researches in quantitative structure–activity relationship (QSAR) and quantitative structure–property relationship (QSPR). With the growing number of ensemble learning models such as random forest, the effectiveness of QSAR/QSPR will be limited by the machine's inability to interpret the predictions to researchers. In fact, many implementations of ensemble learning models are able to quantify the overall magnitude of each feature. For example, feature importance allows us to assess the relative importance of features and to interpret the predictions. However, different ensemble learning methods or implementations may lead to different feature selections for interpretation. In this paper, we compared the predictability and interpretability of four typical well-established ensemble learning models (Random forest, extreme randomized trees, adaptive boosting and gradient boosting) for regression and binary classification modeling tasks. Then, the blending methods were built by summarizing four different ensemble learning methods. The blending method led to better performance and a unification interpretation by summarizing individual predictions from different learning models. The important features of two case studies which gave us some valuable information to compound properties were discussed in detail in this report. QSPR modeling with interpretable machine learning techniques can move the chemical design forward to work more efficiently, confirm hypothesis and establish knowledge for better results. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
37. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
- Author
-
Saito, Hirotaka, Tanaka, Kenichi, Fujiwara, Momoko, Iwasaki, Tsuyoshi, Numata, Tokutaro, Oda, Akira, Kanno, Makoto, Tanaka, Mizuko, Eiro, Masaaki, Satoh, Mamoru, and Kazama, Junichiro James
- Published
- 2019
- Full Text
- View/download PDF
38. Transfusion Requirements in Anesthesia and Intensive Care.
- Author
-
Bolliger, Daniel, Buser, Andreas, and Tanaka, Kenichi A.
- Published
- 2019
- Full Text
- View/download PDF
39. Intraoperative red blood cell transfusion, delayed graft function, and infection after kidney transplant: an observational cohort study.
- Author
-
Mazzeffi, Michael, Jonna, Srikar, Blanco, Natalia, Mavrothalassitis, Orestes, Odekwu, Obi, Fontaine, Magali, Rock, Peter, Tanaka, Kenichi, and Thom, Kerri
- Subjects
RED blood cell transfusion ,KIDNEY transplant patients ,COHORT analysis ,CHRONIC kidney failure ,IMMUNOSUPPRESSIVE agents ,PATIENTS - Abstract
Background: Kidney transplant patients are frequently anemic and at risk for red blood cell (RBC) transfusion. Previous studies suggest that pre-transplant RBC transfusion may improve kidney transplant outcomes; however, RBC transfusion is also associated with infection. The purpose of our study was to characterize the relationships between intraoperative RBC transfusion, delayed graft function (DGF), postoperative surgical site infection (SSI), and sepsis.Methods: Analysis was performed on a historical cohort of adult kidney transplant patients from a single medical center during a two-year period. Crude odds ratios for DGF, superficial and deep SSI, and sepsis were calculated for transfused patients and multivariate regression was used to control for potential confounders when significant relationships were identified.Results: Four hundred forty-one patients had kidney transplant during the study period; 27.0% had RBC transfusion, 38.8% had DGF, 7.0% had superficial SSI, 7.9% had deep SSI, and 1.8% had sepsis. High dose RBC transfusion was associated with improved graft function, but this was negated after adjusting for confounders (OR = 0.86, 95% CI 0.26 to 2.88). There was no association between RBC transfusion and SSI. RBC transfusion was independently associated with sepsis (OR = 8.98, 95% CI 1.52 to 53.22), but the confidence interval was wide.Conclusions: Intraoperative RBC transfusion during kidney transplant is not associated with improved allograft function or incisional SSI, but is associated with postoperative sepsis. RBCs should not be liberally transfused during kidney transplant surgery to improve graft outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
40. Random Forest Approach to QSPR Study of Fluorescence Properties Combining Quantum Chemical Descriptors and Solvent Conditions.
- Author
-
Chen, Chia-Hsiu, Tanaka, Kenichi, and Funatsu, Kimito
- Subjects
- *
RANDOM forest algorithms , *FLUORESCENCE spectroscopy , *QUANTUM chemistry , *SOLVENTS , *CHROMOPHORES , *PREDICTION models - Abstract
The Quantitative Structure - Property Relationship (QSPR) approach was performed to study the fluorescence absorption wavelengths and emission wavelengths of 413 fluorescent dyes in different solvent conditions. The dyes included the chromophore derivatives of cyanine, xanthene, coumarin, pyrene, naphthalene, anthracene and etc., with the wavelength ranging from 250 nm to 800 nm. An ensemble method, random forest (RF), was employed to construct nonlinear prediction models compared with the results of linear partial least squares and nonlinear support vector machine regression models. Quantum chemical descriptors derived from density functional theory method and solvent information were also used by constructing models. The best prediction results were obtained from RF model, with the squared correlation coefficients Rpred2
of 0.940 and 0.905 for λabs and λem, respectively. The descriptors used in the models were discussed in detail in this report by comparing the feature importance of RF. [ABSTRACT FROM AUTHOR] - Published
- 2018
- Full Text
- View/download PDF
41. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis.
- Author
-
Kitajima, Yoichiro, Takahashi, Hirokazu, Akiyama, Takumi, Murayama, Kenichiro, Iwane, Shinji, Kuwashiro, Takuya, Tanaka, Kenichi, Kawazoe, Seiji, Ono, Naofumi, Eguchi, Takahisa, Anzai, Keizo, and Eguchi, Yuichiro
- Subjects
SARCOPENIA ,CIRRHOSIS of the liver ,BRANCHED chain amino acids ,GLUCOSE metabolism ,COMPUTED tomography ,PREVENTION ,THERAPEUTICS ,ADIPOSE tissues ,BLOOD protein disorders ,BLOOD sugar ,DIETARY supplements ,LONGITUDINAL method ,NONPARAMETRIC statistics ,PROGNOSIS ,RESEARCH funding ,SERUM albumin ,SURVIVAL ,EQUIPMENT & supplies ,BODY mass index ,SKELETAL muscle ,KAPLAN-Meier estimator ,DISEASE complications - Abstract
Background: Liver cirrhosis induces marked metabolic disorders, protein-energy malnutrition, and sarcopenia. The objective of the study reported here was to investigate the effects of dietary branched-chain amino acids (BCAAs) on systemic glucose metabolism, skeletal muscle, and prognosis of patients with liver cirrhosis.Methods: Japanese patients with liver cirrhosis (n = 21) were enrolled into a longitudinal study in which their diets were supplemented with BCAAs. We evaluated glucose metabolism and analyzed the skeletal muscle area index (SAI) and intramuscular adipose tissue content (IMAC) using computed tomography.Results: After 48 weeks of supplementation with BCAAs, there were no changes in glucose metabolism and skeletal muscle findings. In patients with ameliorated hypoalbuminemia, IMAC was significantly decreased and SAI was preserved concomitant with decreasing 90- and 120-min post-challenge plasma glucose levels (P < 0.01 each). In patients without increased albumin levels, IMAC was significantly increased and the SAI was significantly decreased (P < 0.01 each). Liver-related event-free survival rates for 72 months were 63.6% in patients with decreased IMAC and 20.0% in patients with increased IMAC.Conclusions: Amelioration of hypoalbuminemia associated with BCAA supplementation correlated with decreased fat accumulation in skeletal muscle, maintenance of skeletal muscle mass, and improved glucose sensitivity, all factors which may contribute to improving the survival of patients with liver cirrhosis. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
42. Whole Blood Assay: Thromboelastometry.
- Author
-
Görlinger, Klaus, Iqbal, Jameel, Dirkmann, Daniel, and Tanaka, Kenichi A.
- Published
- 2016
- Full Text
- View/download PDF
43. Coagulation Management Strategies in Cardiac Surgery.
- Author
-
Bolliger, Daniel and Tanaka, Kenichi
- Published
- 2017
- Full Text
- View/download PDF
44. Determination of the thermal and epithermal neutron sensitivities of an LBO chamber.
- Author
-
Endo, Satoru, Sato, Hitoshi, Shimazaki, Takuto, Nakajima, Erika, Kotani, Kei, Suda, Mitsuru, Hamano, Tsuyoshi, Kajimoto, Tsuyoshi, Tanaka, Kenichi, and Hoshi, Masaharu
- Abstract
An LBO (LiBO) walled ionization chamber was designed to monitor the epithermal neutron fluence in boron neutron capture therapy clinical irradiation. The thermal and epithermal neutron sensitivities of the device were evaluated using accelerator neutrons from the Be(d, n) reaction at a deuteron energy of 4 MeV (4 MeV d-Be neutrons). The response of the chamber in terms of the electric charge induced in the LBO chamber was compared with the thermal and epithermal neutron fluences measured using the gold-foil activation method. The thermal and epithermal neutron sensitivities obtained were expressed in units of pC cm, i.e., from the chamber response divided by neutron fluence (cm). The measured LBO chamber sensitivities were 2.23 × 10 ± 0.34 × 10 (pC cm) for thermal neutrons and 2.00 × 10 ± 0.12 × 10 (pC cm) for epithermal neutrons. This shows that the LBO chamber is sufficiently sensitive to epithermal neutrons to be useful for epithermal neutron monitoring in BNCT irradiation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
45. Efficacy of linagliptin and teneligliptin for glycemic control in type 2 diabetic patients with chronic kidney disease: assessment by continuous glucose monitoring; a pilot study.
- Author
-
Tanaka, Kenichi, Okada, Yosuke, Mori, Hiroko, Inada, Yoshifumi, Suzuka, Kanako, Uriu, Kohei, and Tanaka, Yoshiya
- Abstract
Introduction: Type 2 diabetes patients complicated by chronic kidney disease (CKD) require restricted use and dose adjustment of orally administered hypoglycemic agents because of renal dysfunction, and treatment is likely to be difficult. Linagliptin and teneligliptin are dipeptidyl-peptidase (DPP)-4 inhibitors that do not require dose adjustment even in type 2 diabetes patients complicated by CKD. The aim of this pilot study was to determine the efficacy of these agents for glycemic control using continuous glucose monitoring (CGM). Materials and methods: A randomized crossover study was conducted in 13 type 2 diabetes patients with CKD who maintained glycosylated hemoglobin (HbA) levels at <9 % by diet and exercise and had estimated glomerular filtration rates (eGFRs) <60 ml/min 1.73 m. They were treated with teneligliptin at 20 mg/day or linagliptin at 5 mg/day for 6 days then switched to the other agent for another 6 days. CGM was performed before and during treatment. The primary outcome was changes in mean amplitude of glucose excursions (MAGE). Results: Mean MAGE was 83.8 ± 34.0 and 82.6 ± 32.6 [±standard deviation (SD)] during treatment with linagliptin and teneligliptin, respectively, with no significant difference between agents. The two agents showed comparable beneficial effects on 24-h mean sensor glucose levels and area under the curve for sensor glucose levels ≥180 mg/dl (AUC ≥180), and their use was associated with comparable incidence of hypoglycemia. Conclusions: Linagliptin and teneligliptin have comparable effects on MAGE in type 2 diabetes patients with CKD and are potentially useful and safe for treatment of such patients. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
46. Therapeutic plasma exchange in heart transplantation: role of coagulation assessment with thromboelastometry.
- Author
-
Crabbe, Andrew, McNeil, John, Deshpande, Seema, Kon, Zachary, Pham, Si, and Tanaka, Kenichi
- Subjects
PLASMA exchange (Therapeutics) ,HEART transplantation ,BLOOD coagulation factors ,BLOOD coagulation disorders ,WOMEN patients ,CARDIOMYOPATHIES ,PATIENTS - Abstract
Therapeutic plasma exchange (TPE) is a potentially life-saving procedure which effectively removes donor-specific human leukocyte antigen (HLA) antibodies from the bloodstream, allowing critically ill heart transplant recipients to receive a donor organ with less wait time, and reducing the risk of acute organ rejection. The bulk of coagulation factors is initially removed from the blood during TPE using albumin and is later replaced with allogeneic plasma. Coagulopathy may develop during TPE and then can persist due to intraoperative blood loss and hemodilution during surgery and cardiopulmonary bypass. We hereby describe the utility of rotational thromboelastometry to assess rapid coagulation changes during TPE and subsequent heart transplant (HT) surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
47. Impact of aspirin use on morbidity and mortality in massively transfused cardiac surgery patients: a propensity score matched cohort study.
- Author
-
Mazzeffi, Michael, Galvagno, Samuel, Gammie, James, and Tanaka, Kenichi
- Subjects
PHYSIOLOGICAL effects of aspirin ,CARDIAC surgery patients ,BLOOD transfusion ,LUNG injuries ,PREOPERATIVE care - Abstract
Purpose: Aspirin may prevent organ dysfunction in critically ill patients and mitigate transfusion associated acute lung injury. We hypothesized that aspirin use might be associated with decreased morbidity and mortality in massively transfused cardiac surgery patients. Methods: A single center retrospective cohort study was performed using data from an 8.5-year period (2006-2014). Massive transfusion was defined as receiving at least 2400 ml (8 units) of red blood cell units intraoperatively. A propensity score model was created to account for the likelihood of receiving aspirin and matched pairs were identified using global optimal matching. The primary endpoint, in-hospital mortality, was compared between aspirin users and non-users. Secondary outcomes including: ICU hours, mechanical lung ventilation hours, prolonged mechanical lung ventilation (>24 h), pneumonia, stroke, acute renal failure, atrial fibrillation, deep sternal wound infection, and multiple organ dysfunction syndrome were also compared. Results: Of 7492 cardiac surgery patients, 452 (6 %) were massively transfused and mortality was 30.6 %. There were 346 patients included in the matched cohort. No significant association was found between preoperative aspirin use and in-hospital mortality; absolute risk reduction with aspirin = 7.5 % (95 % CI −2.0 to 16.9 %, p = 0.12). Preoperative aspirin use was associated with fewer total mechanical lung ventilation hours ( p = 0.02) and less prolonged mechanical lung ventilation; absolute risk reduction = 11.0 % (95 % CI 1.1-20.5 %, p = 0.02). Conclusions: Preoperative aspirin use is not associated with decreased in-hospital mortality in massively transfused cardiac surgery patients, but may be associated with less mechanical lung ventilation time. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
48. Seize the Day.
- Author
-
Sniecinski, Roman M., Wittwer, Erica D., Tanaka, Kenichi, and Zaidan, James
- Published
- 2015
- Full Text
- View/download PDF
49. Correction to: Thrombin Generation in Trauma Patients: How Do We Navigate Through Scylla and Charybdis?
- Author
-
Mitrophanov, Alexander Y., Vandyck, Kofi, and Tanaka, Kenichi A.
- Published
- 2022
- Full Text
- View/download PDF
50. Can the intraoperative leak test prevent postoperative leakage of esophagojejunal anastomosis after total gastrectomy?
- Author
-
Kanaji, Shingo, Ohyama, Masato, Yasuda, Takashi, Sendo, Hiroyoshi, Suzuki, Satoshi, Kawasaki, Kentaro, Tanaka, Kenichi, Fujino, Yasuhiro, Tominaga, Masahiro, and Kakeji, Yoshihiro
- Subjects
GASTRECTOMY ,SUTURING ,STOMACH cancer ,CANCER patients ,QUALITY of life ,POSTOPERATIVE care - Abstract
Purpose: Anastomotic failures that cannot be detected during surgery often lead to postoperative leakage. There have been no detailed reports on the intraoperative leak test for esophagojejunal anastomosis. Our purpose was to investigate the utility of routine intraoperative leak testing to prevent postoperative anastomotic leakage after performing esophagojejunostomy. Methods: We prospectively performed routine air leak tests and reviewed the records of 185 consecutive patients with gastric cancer who underwent open total gastrectomy followed by esophagojejunostomy. Results: A positive leak test was found for six patients (3.2 %). These patients with positive leak tests were subsequently treated with additional suturing, and they developed no postoperative anastomotic leakage. However, anastomotic leakage occurred in nine patients (4.9 %) with negative leak tests. A multivariate analysis demonstrated that a patient age >75 years and the surgeon's experience <30 cases were risk factors for anastomotic leakage. Conclusion: Intraoperative leak testing can detect some physical dehiscence, and additional suturing may prevent anastomotic leakage. However, it cannot prevent all anastomotic leakage caused by other factors, such as the surgeons' experience and patients' age. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.